Altus® is focused on developing and commercializing novel protein therapeutics for patients with chronic gastrointestinal and metabolic diseases. Altus' in-depth knowledge of protein crystallization has resulted in a proprietary pipeline of orally-delivered and injectable protein replacement products. As a company, we are committed to improving the quality of life of patients.
Altus is developing a broad portfolio of products based on its novel protein crystallization technology. The company has the potential to redefine the use of biopharmaceutical proteins for gastrointestinal or metabolic diseases by allowing the oral and parenteral delivery of high value protein replacement products. Altus has talented employees with a clear vision for the future, a vision that is committed to developing high quality products to benefit the well-being of people with unmet medical needs.